You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NK-104

Showing 1 - 25 of 1,208
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers Trial in Austin (Pitavastatin (NK-104), Lopinavir/ritonavir)

Completed
Has Results
  • Healthy Volunteers
  • Austin, Texas
    (unnamed)
Jun 9, 2021

Hyperlipidemia, Dyslipidemia Trial in United States (NK-104-CR, Placebo, Livalo)

Withdrawn
  • Hyperlipidemia
  • Dyslipidemia
  • Beverly Hills, California
  • +44 more
May 6, 2021

Hyperlipidemia, Dyslipidemia Trial in United States (NK-104-CR, Livalo® IR, Placebo (for NK-104-CR))

Withdrawn
  • Hyperlipidemia
  • Dyslipidemia
  • Foley, Alabama
  • +68 more
May 6, 2021

Topical Insulin in Neurotrophic Keratopathy After Diabetic

Not yet recruiting
  • Corneal Ulcer
  • +2 more
  • rapid acting insulin
  • BaNHA, Egypt
    Benha University
Jul 2, 2023

NHL, Relapsed, Adult, B-cell Lymphoma, B-cell Leukemia Trial (KUR-502)

Not yet recruiting
  • NHL, Relapsed, Adult
  • +3 more
  • KUR-502
  • (no location specified)
Aug 2, 2022

Cancer, MDS-EB, MDS Trial in Athens, Southampton, Sheffield (INKmune)

Recruiting
  • Cancer
  • +4 more
  • INKmune
  • Athens, Attiki, Greece
  • +2 more
Jul 3, 2023

Meniere's Disease Trial in San Diego (OTO-104)

Terminated
Has Results
  • Meniere's Disease
  • San Diego, California
    Many sites in Europe. Refer to the contact info listed below.
Dec 28, 2022

Meniere's Disease Trial in San Diego (OTO-104)

Terminated
Has Results
  • Meniere's Disease
  • San Diego, California
    Many sites in US. Refer to the contact info listed below.
Nov 16, 2022

Advanced Malignant Tumors Trial (AK127 Q3W IV infusion ,AK104 10mg/kg Q3W IV infusion)

Not yet recruiting
  • Advanced Malignant Tumors
  • AK127 Q3W IV infusion ,AK104 10mg/kg Q3W IV infusion
  • (no location specified)
May 11, 2023

Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)

Recruiting
  • Extranodal NK T Cell Lymphoma
  • NK-Cell Leukemia
  • Anti-CD56 CAR T
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Jul 10, 2023

Advanced Solid Tumor (Phase 1), Pancreatic Adenocarcinoma, Malignant Melanoma (Cutaneous) Trial in United States (IMM-1-104)

Recruiting
  • Advanced Solid Tumor (Phase 1)
  • +4 more
  • Duarte, California
  • +4 more
Feb 2, 2023

Dermatitis Atopic Trial (dupilumab)

Not yet recruiting
  • Dermatitis Atopic
  • (no location specified)
Aug 1, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Cytokine-Induced Memory-like Natural Killer Cells
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 22, 2023

Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax, NK Cells)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M.D. Anderson Cancer Center
Apr 17, 2023

Myeloma Trial in Houston (Fludarabine phosphate, Cyclophosphamide, NY-ESO-1 TCR/IL-15 NK)

Not yet recruiting
  • Myeloma
  • Fludarabine phosphate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2023

Acute Myeloid Leukemia Trial in Xuzhou (allogenic NK cells)

Recruiting
  • Acute Myeloid Leukemia
  • allogenic NK cells
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023

Surgical Wait Time for Knee Arthroplasty Quality of Life in

Not yet recruiting
  • Knee Osteoarthritis
  • questionnaires
  • Hoorn, Noord-Holland, Netherlands
    Dijklander Hospital
Nov 8, 2023

Immunotherapy, Multiple Myeloma Trial in Zhengzhou (Chimeric Antigen Receptor NK Cell Injection Targeting BCMA (BCMA CAR-NK))

Recruiting
  • Immunotherapy
  • Multiple Myeloma
  • Chimeric Antigen Receptor NK Cell Injection Targeting BCMA (BCMA CAR-NK)
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Dec 14, 2022

Anatomic Stage IV Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in Columbus (procedure, drug, biological)

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • HER2-Negative Breast Carcinoma
  • Biospecimen Collection
  • +5 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 30, 2023

Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Xuzhou (allogenic CD19-CAR-NK cells)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • allogenic CD19-CAR-NK cells
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Feb 11, 2023

Hyperlipidemias Trial in Seoul (AD-104-A)

Not yet recruiting
  • Hyperlipidemias
  • Seoul, Jongno-gu, Korea, Republic of
    Seoul National University Hospital
Jan 26, 2023

Advanced Melanoma, Metastatic Melanoma Trial in Saint Louis (Memory-like natural killer cells, Relatilmab, Nivolumab)

Not yet recruiting
  • Advanced Melanoma
  • Metastatic Melanoma
  • Memory-like natural killer cells
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 16, 2022

Immunity, Innate, Colorectal Cancer Trial in Montreal (IVDD for NK cell activity in whole blood)

Terminated
  • Immunity, Innate
  • Colorectal Cancer
  • IVDD for NK cell activity in whole blood
  • Montreal, Quebec, Canada
  • +2 more
Jan 30, 2023

Acute Myeloid Leukemia Trial in Columbus (Universal Donor Natural Killer Cells)

Recruiting
  • Acute Myeloid Leukemia
  • Universal Donor Natural Killer Cells
  • Columbus, Ohio
    Nationwide Children's Hospital
Aug 11, 2022

Idiopathic Recurrent Pericarditis Trial in Saint Petersburg (RPH-104)

Active, not recruiting
  • Idiopathic Recurrent Pericarditis
  • RPH-104
  • Saint Petersburg, Russian Federation
    National medical research center named after V. A. Almazov
Dec 21, 2022